Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

Despite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of patients achieving five-year survival remains low, according to new Mayo Clinic research.

* This article was originally published here